Possibility of ocular absorption of nebuliser aerosols.
R P
RP
Taylor
D000042:Absorption; D000287:Administration, Topical; D000336:Aerosols; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000378:metabolism*; D001993:Bronchodilator Agents / Q000008:administration & dosage* / Q000378:metabolism*; D019819:Budesonide; D005123:Eye / Q000378:metabolism*; D005260:Female; D005901:Glaucoma / Q000150:complications; D005938:Glucocorticoids; D006801:Humans; D009241:Ipratropium / Q000008:administration & dosage* / Q000378:metabolism*; D008173:Lung Diseases, Obstructive / Q000150:complications / Q000188:drug therapy*; D009330:Nebulizers and Vaporizers; D011282:Pregnenediones / Q000008:administration & dosage* / Q000378:metabolism*
D000336:Aerosols; D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D005938:Glucocorticoids; D011282:Pregnenediones; D019819:Budesonide; D009241:Ipratropium